Condensed Consolidated Statements of Stockholders' (Deficit)/Equity - USD ($) |
Common Stock [Member] |
Treasury Stock [Member] |
Paid-in Capital [Member] |
Accumulated Deficit [Member] |
Total Stockholders’ (Deficit)/ Equity [Member] |
Noncontrolling Interest [Membet] |
Total |
|||
|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2023 | $ 8,800 | $ 0 | $ 0 | $ (66,770,700) | $ (66,761,900) | $ 0 | $ (66,761,900) | |||
| Balance (in Shares) at Dec. 31, 2023 | 87,500,000 | |||||||||
| Balance (in Shares) at Dec. 31, 2023 | 0 | |||||||||
| Fair value of TMTG earnout shares | $ 0 | $ 0 | 2,477,550,200 | (2,477,550,200) | 0 | 0 | 0 | |||
| Conversion of convertible notes upon reverse capitalization | $ 600 | $ 0 | 300,425,400 | 0 | 300,426,000 | 0 | 300,426,000 | |||
| Conversion of convertible notes upon reverse capitalization (in Shares) | 6,014,534 | 0 | ||||||||
| Stock based compensation | $ 200 | $ 0 | 84,587,800 | 0 | 84,588,000 | 0 | 84,588,000 | |||
| Stock based compensation (in Shares) | 1,840,000 | 0 | ||||||||
| Issuance of common stock upon reverse capitalization | $ 4,100 | $ 0 | 219,617,500 | 0 | 219,621,600 | 0 | 219,621,600 | |||
| Issuance of common stock upon reverse capitalization (in Shares) | 41,346,049 | 0 | ||||||||
| Net loss | $ 0 | $ 0 | 0 | (327,599,700) | (327,599,700) | 0 | (327,599,700) | |||
| Balance at Mar. 31, 2024 | $ 13,700 | $ 0 | 3,082,180,900 | (2,871,920,600) | 210,274,000 | 0 | 210,274,000 | |||
| Balance (in Shares) at Mar. 31, 2024 | 136,700,583 | |||||||||
| Balance (in Shares) at Mar. 31, 2024 | 0 | |||||||||
| Balance at Dec. 31, 2023 | $ 8,800 | $ 0 | 0 | (66,770,700) | (66,761,900) | 0 | (66,761,900) | |||
| Balance (in Shares) at Dec. 31, 2023 | 87,500,000 | |||||||||
| Balance (in Shares) at Dec. 31, 2023 | 0 | |||||||||
| Net loss | (343,967,700) | |||||||||
| Balance at Jun. 30, 2024 | $ 19,200 | $ 0 | 3,229,937,700 | (2,888,288,600) | 341,668,300 | 0 | 341,668,300 | |||
| Balance (in Shares) at Jun. 30, 2024 | 191,477,375 | |||||||||
| Balance (in Shares) at Jun. 30, 2024 | 0 | |||||||||
| Balance at Mar. 31, 2024 | $ 13,700 | $ 0 | 3,082,180,900 | (2,871,920,600) | 210,274,000 | 0 | 210,274,000 | |||
| Balance (in Shares) at Mar. 31, 2024 | 136,700,583 | |||||||||
| Balance (in Shares) at Mar. 31, 2024 | 0 | |||||||||
| Exercise of warrants | $ 900 | $ 0 | 97,761,400 | 0 | 97,762,300 | 0 | 97,762,300 | |||
| Exercise of warrants (in Shares) | 8,526,792 | |||||||||
| Exercise of warrants (in Shares) | 0 | |||||||||
| Issuance of earnout shares | $ 4,000 | $ 0 | (4,000) | 0 | 0 | 0 | 0 | |||
| Issuance of earnout shares (in Shares) | 40,000,000 | |||||||||
| Issuance of earnout shares (in Shares) | 0 | |||||||||
| Conversion of convertible notes into common stock | $ 600 | $ 0 | 49,999,400 | 0 | 50,000,000 | 0 | 50,000,000 | |||
| Conversion of convertible notes into common stock (in Shares) | 6,250,000 | |||||||||
| Conversion of convertible notes into common stock (in Shares) | 0 | |||||||||
| Net loss | $ 0 | $ 0 | 0 | (16,368,000) | (16,368,000) | 0 | (16,368,000) | |||
| Balance at Jun. 30, 2024 | $ 19,200 | $ 0 | 3,229,937,700 | (2,888,288,600) | 341,668,300 | 0 | 341,668,300 | |||
| Balance (in Shares) at Jun. 30, 2024 | 191,477,375 | |||||||||
| Balance (in Shares) at Jun. 30, 2024 | 0 | |||||||||
| Balance at Dec. 31, 2024 | $ 22,100 | $ (2,908,700) | 3,861,662,400 | (2,945,185,700) | 913,590,100 | 0 | $ 913,590,100 | |||
| Balance (in Shares) at Dec. 31, 2024 | 220,785,152 | |||||||||
| Balance (in Shares) at Dec. 31, 2024 | (128,138) | (128,138) | ||||||||
| Stock based compensation | $ 0 | $ 0 | 17,851,700 | 0 | 17,851,700 | 0 | $ 17,851,700 | |||
| Stock based compensation (in Shares) | 0 | 0 | ||||||||
| Treasury stock | $ 0 | $ (8,250,200) | 0 | 0 | (8,250,200) | 0 | (8,250,200) | |||
| Treasury stock (in Shares) | (296,345) | |||||||||
| Vesting of restricted stock units | $ 0 | $ 0 | 0 | 0 | 0 | 0 | 0 | |||
| Vesting of restricted stock units (in Shares) | 243,411 | 0 | ||||||||
| Exercise of warrants | $ 0 | $ 0 | 221,500 | 0 | 221,500 | 0 | 221,500 | |||
| Exercise of warrants (in Shares) | 19,292 | |||||||||
| Exercise of warrants (in Shares) | 0 | |||||||||
| Net loss | $ 0 | $ 0 | 0 | (31,726,600) | (31,726,600) | 0 | (31,726,600) | |||
| Balance at Mar. 31, 2025 | $ 22,100 | $ (11,158,900) | 3,879,735,600 | (2,976,912,300) | 891,686,500 | 0 | 891,686,500 | |||
| Balance (in Shares) at Mar. 31, 2025 | 221,047,855 | |||||||||
| Balance (in Shares) at Mar. 31, 2025 | (424,483) | |||||||||
| Balance at Dec. 31, 2024 | $ 22,100 | $ (2,908,700) | 3,861,662,400 | (2,945,185,700) | 913,590,100 | 0 | $ 913,590,100 | |||
| Balance (in Shares) at Dec. 31, 2024 | 220,785,152 | |||||||||
| Balance (in Shares) at Dec. 31, 2024 | (128,138) | (128,138) | ||||||||
| Net loss | $ (51,728,500) | |||||||||
| Balance at Jun. 30, 2025 | $ 27,800 | $ (11,158,900) | 5,289,923,600 | (2,996,894,600) | 2,281,897,900 | 230,400 | $ 2,282,128,300 | [1] | ||
| Balance (in Shares) at Jun. 30, 2025 | 277,734,676 | |||||||||
| Balance (in Shares) at Jun. 30, 2025 | (424,483) | (424,483) | [1] | |||||||
| Balance at Mar. 31, 2025 | $ 22,100 | $ (11,158,900) | 3,879,735,600 | (2,976,912,300) | 891,686,500 | 0 | $ 891,686,500 | |||
| Balance (in Shares) at Mar. 31, 2025 | 221,047,855 | |||||||||
| Balance (in Shares) at Mar. 31, 2025 | (424,483) | |||||||||
| Stock based compensation | $ 0 | $ 0 | 17,744,600 | 0 | 17,744,600 | 0 | 17,744,600 | |||
| Stock based compensation (in Shares) | 0 | 0 | ||||||||
| Common stock issued in PIPE | $ 5,600 | $ 0 | 1,392,401,400 | 0 | 1,392,407,000 | 0 | 1,392,407,000 | |||
| Common stock issued in PIPE (in Shares) | 55,857,181 | |||||||||
| Common stock issued in PIPE (in Shares) | 0 | |||||||||
| Vesting of restricted stock units | $ 100 | $ 0 | (100) | 0 | 0 | 0 | 0 | |||
| Vesting of restricted stock units (in Shares) | 825,981 | 0 | ||||||||
| Non-controlling interest contribution | $ 0 | $ 0 | 0 | 0 | 0 | 250,000 | 250,000 | |||
| Exercise of warrants | $ 0 | $ 0 | 42,100 | 0 | 42,100 | 0 | 42,100 | |||
| Exercise of warrants (in Shares) | 3,659 | |||||||||
| Exercise of warrants (in Shares) | 0 | |||||||||
| Net loss | $ 0 | $ 0 | 0 | (19,982,300) | (19,982,300) | (19,600) | (20,001,900) | |||
| Balance at Jun. 30, 2025 | $ 27,800 | $ (11,158,900) | $ 5,289,923,600 | $ (2,996,894,600) | $ 2,281,897,900 | $ 230,400 | $ 2,282,128,300 | [1] | ||
| Balance (in Shares) at Jun. 30, 2025 | 277,734,676 | |||||||||
| Balance (in Shares) at Jun. 30, 2025 | (424,483) | (424,483) | [1] | |||||||
| ||||||||||
| X | ||||||||||
- Definition Amount of increase (decrease) in additional paid in capital (APIC) resulting from fair value of earnout shares. No definition available.
|
| X | ||||||||||
- Definition Number of stock issued upon issuance of common shares issued in PIPE. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities, upon reverse capitalization. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible notes to common stock. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued as a result of the exercise of warrants during the period. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period issuance of common stock upon reverse capitalization. No definition available.
|
| X | ||||||||||
- Definition Value of stock issued upon issuance of common shares issued in PIPE. No definition available.
|
| X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities, upon reverse capitalization. No definition available.
|
| X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible notes to common stock. No definition available.
|
| X | ||||||||||
- Definition Value of stock issued during the period as exercise of warrants. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of issuance of earnout shares. No definition available.
|
| X | ||||||||||
- Definition Value of issuance of common stock upon reverse capitalization. No definition available.
|
| X | ||||||||||
- Definition Number of earnout shares issued during the period. No definition available.
|
| X | ||||||||||
- Definition Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of a stock split. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased during the period and are being held in treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|